Analyst Recommendations

Deutsche Bank analyst issues BUY recommendation for THLLY on April 9, 2024 02:09PM ET. The previous analyst recommendation was Buy.THLLY was trading at $33.53 at issue of the...

April 9, 2024   THLLY 1.60%

Goldman Sachs analyst issues NEUTRAL recommendation for CHPT on April 9, 2024 12:29PM ET. The previous analyst recommendation was Sell.CHPT was trading at $1.765 at issue of the...

April 9, 2024   CHPT -3.91%

Jefferies analyst issues BUY recommendation for ALKS on April 9, 2024 12:04PM ET. The previous analyst recommendation was Buy.ALKS was trading at $27 at issue of the analyst...

April 9, 2024   ALKS -0.59%

Oppenheimer analyst issues UNDERPERFORM recommendation for CUE on April 9, 2024 10:01AM ET. The previous analyst recommendation was Underperform.CUE was trading at $1.9 at issue of the analyst...

April 9, 2024   CUE -3.77%

Susquehanna analyst issues BUY recommendation for BABA on April 9, 2024 10:01AM ET. The previous analyst recommendation was Buy.BABA was trading at $72.7012 at issue of the analyst...

April 9, 2024   BABA 0.08%

Morgan Stanley analyst issues OVERWEIGHT recommendation for DKNG on April 9, 2024 11:40AM ET. The previous analyst recommendation was Overweight.DKNG was trading at $44.95 at issue of the...

April 9, 2024   DKNG -3.57%

BMO Capital analyst issues OUTPERFORM recommendation for TGB on April 9, 2024 11:00AM ET. The previous analyst recommendation was Outperform.TGB was trading at $2.52 at issue of the...

April 9, 2024   TGB -1.91%

Morgan Stanley analyst issues OVERWEIGHT recommendation for LVS on April 9, 2024 11:42AM ET. The previous analyst recommendation was Overweight.LVS was trading at $52.22 at issue of the...

April 9, 2024   LVS -1.41%

Stephens analyst issues EQUAL-WEIGHT recommendation for KMX on April 9, 2024 11:13AM ET. The previous analyst recommendation was Equal-Weight.KMX was trading at $83.01 at issue of the analyst...

April 9, 2024   KMX -3.88%

RBC Capital analyst issues UNDERPERFORM recommendation for PCRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Underperform.PCRX was trading at $28.44 at issue of the...

April 9, 2024   PCRX -3.33%